UGRO Capital board meet April 20 for FY26 results

What the company has announced

UGRO Capital Limited said its Board of Directors will meet on April 20, 2026. The company indicated that the meeting will consider and approve the audited financial results for the full year ended March 31, 2026 (FY26). Alongside the results, the board will evaluate proposals to raise funds through both debt and equity. UGRO Capital also plans to approve the convening of its 33rd Annual General Meeting (AGM). For investors, this meeting is positioned as a key checkpoint because it combines the final FY26 numbers with decisions that can shape the funding roadmap.

Board agenda: FY26 results, fundraising and the 33rd AGM

The main item on the agenda is approval of audited financial results for FY26. Audited full-year results typically provide clarity on year-end asset quality, provisioning, and profitability trends that may not be fully visible in quarterly snapshots. The board will also consider fundraising proposals spanning debt and equity routes. In addition, the company plans to approve steps related to convening the 33rd AGM, which sets the timeline for shareholder-facing disclosures and voting items.

Why the April 20 meeting matters for shareholders

The April 20 board meeting is expected to deliver official FY26 figures for UGRO Capital’s financial performance. Investors often focus on how full-year audited results reconcile with the growth and asset-quality commentary provided during quarterly updates. The fundraising discussion is another central focus because it signals how the company intends to fund balance sheet growth and manage capital adequacy. Any approved fundraising plan can also influence the company’s future cost of funds, leverage strategy, and liquidity posture, depending on the mix of instruments.

Recent quarterly snapshot: Q3 FY26 performance

In the most recently reported quarter cited, Q3 FY26, UGRO Capital reported consolidated profit after tax (PAT) of ₹46.3 crore, up 23% year-on-year. Total income in the quarter rose 32% year-on-year to ₹506.4 crore. The company’s Assets Under Management (AUM) stood at ₹15,454 crore, up 40% year-on-year. These numbers provide context for the market going into the FY26 audited results, especially on the pace of scaling and the profitability trajectory.

Earlier FY26 indicators: Q1 FY26 operational and financial metrics

UGRO Capital’s Q1 FY26 update also highlighted growth metrics that investors may use as reference points. The company reported AUM of ₹12,081 crore as of June 30, 2025, representing 31% year-on-year growth. Total income in Q1 FY26 was ₹421.8 crore, up 40% year-on-year, while PAT was ₹34.1 crore, up 12% year-on-year. The update also reported a capital adequacy ratio (CRAR) of 22.4% for Q1 FY26. While these numbers are not substitutes for audited full-year results, they form part of the operating trail leading into FY26 close.

Fundraising on the table: debt and equity options

UGRO Capital said the board will consider proposals to raise funds through debt and equity. The company has previously used multiple instruments and formats to access capital markets. One example included approval by its Investment and Borrowing Committee for issuance of listed, rated non-convertible debentures (NCDs) up to ₹500 crore, with a base issue of ₹200 crore and an option to retain ₹300 crore through a greenshoe structure. The NCD plan described multiple series, with tentative tenures including 24 months for certain series and 13 months for another, and a tentative coupon of 9.75% for one series.

The company has also disclosed another NCD approval of up to ₹50 crore via issuance of up to 5,000 unsecured, rated, subordinated, listed NCDs, with an indicative coupon of 11.65% per annum and a tentative tenure of 66 months. These past actions illustrate the variety of debt formats the company has considered, although the April 20 agenda refers broadly to fundraising proposals and does not specify instruments or sizes.

Capital history: prior equity raise approvals and ongoing actions

UGRO Capital has stated it has a track record of strengthening its capital base, including approving an equity raise of ₹1,332.66 crore in May 2024. In its Q1 FY26 communication, the company also referred to an equity raise programme involving a ₹381 crore rights issue that was completed and a ₹911 crore preferential issue in process at that time. Separately, the company commentary also mentioned raising ₹535 crore of equity in October 2025. Investors typically track these actions for signals on dilution, timing, and the company’s medium-term capital planning.

Audit and asset-quality focus: what the FY25 audit excerpt highlights

Alongside the FY26 board meeting update, an audit report excerpt for the year ended March 31, 2025 included a key audit matter on impairment of loans including Expected Credit Loss (ECL). The audit excerpt stated that total loans as at March 31, 2025 were ₹7,919.11 crore (net of ECL), and impairment provision was ₹107.94 crore. The excerpt described the ECL approach under Ind AS 109, and the audit procedures referenced testing controls and reviewing assumptions such as Probability of Default (PD) and Loss Given Default (LGD), staging based on days past due, and related disclosures. While this relates to FY25, it underlines why investors often examine provisioning, credit cost, and portfolio staging closely in audited annual results.

Key numbers mentioned so far

Market impact: what investors will track after April 20

The market focus after the April 20 board meeting is likely to be on two deliverables: the audited FY26 numbers and any board-approved fundraising plan. Audited results can influence investor interpretation of growth quality, especially for an MSME-focused NBFC where underwriting and provisioning assumptions matter. Fundraising decisions, if approved, can also shape near-term balance sheet flexibility by determining the mix of equity versus borrowings and the structure of any debt issuance.

Investors will also look for alignment between quarterly disclosures and the audited outcome, particularly around AUM growth, total income growth, and profitability. With prior references to both debt issuance approvals and equity raise programmes, the board’s discussion on capital raising is a key signal of how UGRO Capital plans to support lending expansion and maintain regulatory capital buffers.

Conclusion

UGRO Capital’s April 20, 2026 board meeting brings together the release of audited FY26 financial results and a review of debt and equity fundraising proposals, along with steps to convene the company’s 33rd AGM. The outcomes will provide shareholders with the official FY26 performance picture and clearer visibility on the company’s funding plans, based on what the board approves.